AstraZeneca pursues mRNA partnership, signs vaccine manufacturing deal with China's CanSino...
The supply agreement will last at least 10 years. Under the deal, CanSino will use its mRNA manufacturing platform to support AZ on the R&D of certain vaccines, the filing shows. The pair may further collaborate on R&D and commercialization in the future.
via https://www.fiercepharma.com/manufacturing/astrazeneca-commits-mrna-signs-vaccine-manufacturing-deal-chinas-cansino
@TheStarkNakedBrief
The supply agreement will last at least 10 years. Under the deal, CanSino will use its mRNA manufacturing platform to support AZ on the R&D of certain vaccines, the filing shows. The pair may further collaborate on R&D and commercialization in the future.
via https://www.fiercepharma.com/manufacturing/astrazeneca-commits-mrna-signs-vaccine-manufacturing-deal-chinas-cansino
@TheStarkNakedBrief
Comments
Be the first to add a comment
Log in to comment